Abstract:Category: Diabetes; Other Introduction/Purpose: Management of recalcitrant diabetic foot ulcer (DFU) remains difficult. Distraction osteogenesis mediates new bone formation and angiogenesis in the bone itself and the surrounding tissues. Recently it was reported that tibial cortex transverse transport (TTT) was associated with neovascularization and increased perfusion at the foot in patients with recalcitrant DFUs and facilitated healing and limb salvage. However, the findings were from several single-center studies with relatively small populations, which need to be confirmed in multicenter cohort studies with relatively large populations. Furthermore, the effect of this technique on patient's health-related quality of life is still unclear. Methods: We treated patients with recalcitrant (University of Texas wound grading system 2-C to 3-D and not responding to prior routine conservative and surgical treatments for at least 8 weeks) DFUs from seven centers using TTT (a 5 cm 1.5 cm corticotomy followed by 4 weeks of medial and lateral distraction) between July 2016 and June 2019. We analyzed ulcer healing, major amputation, recurrence, health-related quality of life (physical and mental component summary scores), and complications in the 2-year follow-up. Foot arterial and perfusion changes were evaluated using computed tomography angiography and perfusion imaging 12 weeks postoperatively. Results: A total of 1175 patients were enrolled. Patients who died (85, 7.2%) or lost to follow-up (18, 1.7%) were excluded, leaving 1072 patients for evaluation. The mean ulcer size was 41.0 8.5 cm 2 and 187 (16.6%) ulcers extended above the ankle. During the follow-up, 1019 (94.9%) patients healed in a mean time of 12.4 5.6 weeks, 53 (4.9%) had major amputations, and 33 (3.1%) experienced recurrences.Closed tibial fracture at the corticotomy site was found in 8 (0.7%) patients and was treated using external fixation and healed uneventfully.Compared to preoperatively, the patients had more small arteries and higher foot blood flow (8.1 2.2 versus 28.3 3.9 ml/100 g/min, p 1⁄4 0.003) and volume (1.5 0.3 versus 2.7 0.4 ml/100 g, p 1⁄4 0.037) 12 weeks postoperatively. Conclusion: TTT promotes healing, limb salvage, and health-related quality of life in patients with recalcitrant DFUs as demonstrated in this multicenter cohort study. The surgical procedure was simple and straightforward and the complications were few and minor. The effect of this technique was associated with neovascularization and improved perfusion at the foot mediated by the cortex distraction. The findings are required to confirm in randomized controlled trials.

A Single Center, Randomized Controlled Trial on the Efficacy of Topical Application of ReGenerating Tissue Agents (RGTA) Technology in Diabetic Foot Ulcers

Efficacy of Topical Recombinant Human Platelet-Derived Growth Factor for Treatment of Diabetic Lower-Extremity Ulcers: Systematic Review and Meta-Analysis

Efficacy Of Topical Recombinant Human Epidermal Growth Factor For Treatment Of Diabetic Foot Ulcer: A Systematic Review And Meta-Analysis

Efficacy of Topical Recombinant Human Epidermal Growth Factor for Treatment of Diabetic Foot Ulcer

Clinical efficacy and mechanism of the combination of autologous platelet-rich gel and recombinant human acidic fibroblast growth factor in the management of refractory diabetic foot

Efficacy and Safety of Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Systematic Review and Meta‐analysis of Randomised Controlled Trials

A clinical trial of Integra Template for diabetic foot ulcer treatment

Efficacy and safety of recombinant human epidermal growth factor for diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials

Treatment with Umbilical Cord Blood Platelet Lysate Gel Improves Healing of Diabetic Foot Ulcer

Clinical Effectiveness Of An Acellular Dermal Regenerative Tissue Matrix Compared To Standard Wound Management In Healing Diabetic Foot Ulcers: A Prospective, Randomised, Multicentre Study

Early identification of delayed wound healing in complex diabetic foot ulcers treated with a dermal regeneration template: a novel clinical target and its risk factors

Autologous Platelet‐rich Gel for Treatment of Diabetic Chronic Refractory Cutaneous Ulcers: A Prospective, Randomized Clinical Trial

Effect of Topical Basic Fibroblast Growth Factor on the Healing of Chronic Diabetic Neuropathic Ulcer of the foot: A pilot, randomized, double-blind, placebo-controlled study

Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Comparison of the Efficacy of Autologous Platelet-Rich Plasma and Saline Dressing in Healing of Diabetic Foot UlcerA Randomised Control Study

A novel approach for the treatment of diabetic foot ulcers using a multimodal wound matrix: a clinical study

Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi‐centre clinical trial with a microvascular tissue allograft

Effect of Tibial Cortex Transverse Transport in Patients with Recalcitrant Diabetic Foot Ulcers: A Prospective Multicenter Cohort Study

Effect of autologous platelet-rich gel on the treatment of diabetic foot ulcers

The Therapeutic Efficacy of Freeze-Dried Human Amniotic Membrane Allograft Gel for Diabetic Foot Ulcers: A Phase-1 Clinical Trial

Major Improvement in Wound Healing Through Pharmacologic Mobilization of Stem Cells in Severely Diabetic Rats